首页> 外文OA文献 >A European multicentre photopatch test study:The European Multicentre Photopatch Test Study (EMCPPTS) taskforce
【2h】

A European multicentre photopatch test study:The European Multicentre Photopatch Test Study (EMCPPTS) taskforce

机译:欧洲多中心Photopatch测试研究:欧洲多中心Photopatch测试研究(EMCPPTS)工作组

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background The two most common agent groups currently responsible for photo-allergic contact dermatitis (PACD) are organic ultraviolet (UV) absorbers in sunscreens and topical nonsteroidal anti-inflammatory drugs (NSAIDs). However, availability of information on the photoallergenic potential of these agents is scarce.</p><p>Objectives To obtain current information on the frequency of PACD to 19 organic UV absorbers and five topical NSAIDs, including newer agents, in common usage in Europe.</p><p>Methods A prospective, multicentre photopatch test study was conducted with 1031 patients attending for investigation of suspected PACD in 30 centres across 12 European countries.</p><p>Results A total of 346 PACD reactions in 200 (19.4%) subjects occurred. PACD was most commonly caused by the topical NSAIDs, ketoprofen (128 subjects) and etofenamate (59 subjects). Of the organic UV absorbers, octocrylene, benzophenone-3 and butyl methoxydibenzoylmethane most frequently elicited PACD. The 'newer' organic sunscreen absorbers rarely led to PACD. There appeared to be an association between the agents ketoprofen, octocrylene and benzophenone-3, with several subjects developing PACD to two or all three agents concomitantly. Allergic contact dermatitis (ACD) was less commonly observed than PACD, comprising 55 reactions in 47 (5%) subjects. Irritant reactions and photoaugmentation and photoinhibition of ACD occurred infrequently.</p><p>Conclusions The European multicentre photopatch test study has provided current information on the relative frequency of PACD to common photoallergens. Such data will be of value when deciding on which agents to include in a future European 'baseline' photopatch test series.</p>
机译:背景技术目前造成光过敏性接触性皮炎(PACD)的两个最常见的药剂是防晒霜中的有机紫外线(UV)吸收剂和局部非甾体类抗炎药(NSAIDs)。然而,有关这些试剂的光致变应性潜力的信息却很少。

目标要获得有关19种有机紫外线吸收剂和5种局部NSAID(包括较新的试剂)的PACD频率的最新信息,通常用于欧洲。

方法进行了一项前瞻性,多中心光斑试验研究,在欧洲12个国家的30个中心对1031名患者进行了可疑PACD调查。

结果总共进行了346次PACD反应。在200名(19.4%)的受试者中。 PACD最常见的是由局部NSAID,酮洛芬(128名受试者)和依托芬酸酯(59名受试者)引起。在有机紫外线吸收剂中,辛二烯,二苯甲酮3和丁基甲氧基二苯甲酰基甲烷最常引起PACD。 “新型”有机防晒吸收剂很少导致PACD。药物酮洛芬,辛二烯和二苯甲酮3之间似乎存在关联,一些受试者同时伴有两种或三种药物发展为PACD。与PACD相比,变应性接触性皮炎(ACD)较少见,在47(5%)个受试者中包含55次反应。结论

结论欧洲多中心光斑试验研究提供了有关PACD与常见光致敏原的相对频率的最新信息。当决定在未来的欧洲“基准”照片修补测试系列中包括哪些代理时,此类数据将很有价值。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号